ATOH1 is a basic helix-loop-helix transcription factor that functions as a key regulator of sensory and secretory cell differentiation. As a transcriptional activator, ATOH1 binds E-box elements and works collaboratively with TCF3/E47 to promote differentiation of specific neural and epithelial cell lineages 1. Its activity is antagonized by the negative regulator HES1, allowing for precise control of cell fate decisions. ATOH1 plays critical roles in multiple tissues. In the intestinal epithelium, ATOH1 directs intestinal stem cell differentiation toward goblet and Paneth cells through the FGF1-FGFR2-TCF4-ATOH1 signaling axis, with goblet cells playing protective roles in inflammatory responses 2. ATOH1 also regulates tuft cell specification, where microbe-derived metabolites like succinate promote tuft cell expansion through ATOH1-dependent mechanisms; tuft cell expansion suppresses ileal inflammation in Crohn's disease models 3. In the inner ear, ATOH1 is essential for hair cell differentiation from pluripotent stem cells, enabling development of functional sensory structures 4. During respiratory system development, ATOH1 contributes to retrotrapezoid nucleus formation, which is critical for central respiratory chemoreception 5. Clinically, ATOH1 dysfunction is associated with deafness, developmental delays, and gastrointestinal pathologies. These findings suggest ATOH1-targeted therapies may benefit patients with hearing loss, inflammatory bowel disease, and regenerative disorders.